Executive Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $249K | Buy |
2,699
+55
| +2% | +$5.08K | 0.02% | 236 |
|
|
2024
Q3 | $222K | Buy |
+2,644
| New | +$222K | 0.02% | 250 |
|
|
2024
Q1 | – | Sell |
-2,622
| Closed | -$212K | – | 247 |
|
|
2023
Q4 | $212K | Sell |
2,622
-67
| -2% | -$5.43K | 0.02% | 206 |
|
|
2023
Q3 | $202K | Sell |
2,689
-142
| -5% | -$10.6K | 0.02% | 193 |
|
|
2023
Q2 | $218K | Buy |
2,831
+27
| +1% | +$2.08K | 0.02% | 189 |
|
|
2023
Q1 | $233K | Buy |
2,804
+11
| +0.4% | +$913 | 0.03% | 180 |
|
|
2022
Q4 | $240K | Buy |
+2,793
| New | +$240K | 0.03% | 170 |
|
|
2019
Q3 | – | Sell |
-594
| Closed | -$40K | – | 381 |
|
|
2019
Q2 | $40K | Buy |
594
+5
| +0.8% | +$337 | 0.01% | 338 |
|
|
2019
Q1 | $38K | Sell |
589
-956
| -62% | -$61.7K | 0.01% | 313 |
|
|
2018
Q4 | $97K | Buy |
+1,545
| New | +$97K | 0.02% | 204 |
|